Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Siriwan Tangjitgamol; Benjamin O. Anderson; Hui Ti See; Chawalit Lertbutsayanukul; Nakarin Sirisabya; Tarinee Manchana; Arunachalam Ilancheran; Khai Mun Lee; Siew Eng Lim; Yin Nin Chia; Efren Domingo; Young Tak Kim; Chyong Huey Lai; Ahmad Zailani Hatta Mohd Dali; Wisit Supakapongkul; Sarikapan Wilailak; Eng Hseon Tay; John Kavanagh

doi:10.1016/S1470-2045(09)70290-6

Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Siriwan Tangjitgamol
, Benjamin O. Anderson
, Hui Ti See
, Chawalit Lertbutsayanukul
, Nakarin Sirisabya
, Tarinee Manchana
, Arunachalam Ilancheran
, Khai Mun Lee
, Siew Eng Lim
, Yin Nin Chia
, Efren Domingo
, Young Tak Kim
, Chyong Huey Lai
, Ahmad Zailani Hatta Mohd Dali
, Wisit Supakapongkul
, Sarikapan Wilailak
, Eng Hseon Tay
, John Kavanagh^*

^*Corresponding author for this work

School of Medicine

Navamindradhiraj University
University of Washington
Gleneagles Hospital
Chulalongkorn University
National University Hospital
KK Women's and Children's Hospital
University of the Philippines
University of Ulsan
Universiti Kebangsaan Malaysia
National Cancer Institute Thailand
Mahidol University
Thomson Medical Centre

Research output: Contribution to journal › Review article › peer-review

66 Scopus citations

Abstract

Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.

Original language	English
Pages (from-to)	1119-1127
Number of pages	9
Journal	The Lancet Oncology
Volume	10
Issue number	11
DOIs	https://doi.org/10.1016/S1470-2045(09)70290-6
State	Published - 11 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

ADJUVANT TREATMENT
FOLLOW-UP
INTERMEDIATE-RISK
MRC ASTEC
PELVIC RADIATION-THERAPY
PHASE-III TRIAL
POSTOPERATIVE RADIOTHERAPY
RANDOMIZED-TRIAL
REPLACEMENT THERAPY
STAGE-I

Access to Document

10.1016/S1470-2045(09)70290-6

Cite this

Tangjitgamol, S., Anderson, B. O., See, H. T., Lertbutsayanukul, C., Sirisabya, N., Manchana, T., Ilancheran, A., Lee, K. M., Lim, S. E., Chia, Y. N., Domingo, E., Kim, Y. T., Lai, C. H., Dali, A. Z. H. M., Supakapongkul, W., Wilailak, S., Tay, E. H., & Kavanagh, J. (2009). Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology, 10(11), 1119-1127. https://doi.org/10.1016/S1470-2045(09)70290-6

@article{1acd8f36561b46bea6f5a0583c46afda,

title = "Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009",

abstract = "Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.",

keywords = "ADJUVANT TREATMENT, FOLLOW-UP, INTERMEDIATE-RISK, MRC ASTEC, PELVIC RADIATION-THERAPY, PHASE-III TRIAL, POSTOPERATIVE RADIOTHERAPY, RANDOMIZED-TRIAL, REPLACEMENT THERAPY, STAGE-I",

author = "Siriwan Tangjitgamol and Anderson, \{Benjamin O.\} and See, \{Hui Ti\} and Chawalit Lertbutsayanukul and Nakarin Sirisabya and Tarinee Manchana and Arunachalam Ilancheran and Lee, \{Khai Mun\} and Lim, \{Siew Eng\} and Chia, \{Yin Nin\} and Efren Domingo and Kim, \{Young Tak\} and Lai, \{Chyong Huey\} and Dali, \{Ahmad Zailani Hatta Mohd\} and Wisit Supakapongkul and Sarikapan Wilailak and Tay, \{Eng Hseon\} and John Kavanagh",

year = "2009",

month = nov,

doi = "10.1016/S1470-2045(09)70290-6",

language = "英语",

volume = "10",

pages = "1119--1127",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "11",

}

Tangjitgamol, S, Anderson, BO, See, HT, Lertbutsayanukul, C, Sirisabya, N, Manchana, T, Ilancheran, A, Lee, KM, Lim, SE, Chia, YN, Domingo, E, Kim, YT, Lai, CH, Dali, AZHM, Supakapongkul, W, Wilailak, S, Tay, EH & Kavanagh, J 2009, 'Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009', The Lancet Oncology, vol. 10, no. 11, pp. 1119-1127. https://doi.org/10.1016/S1470-2045(09)70290-6

TY - JOUR

T1 - Management of endometrial cancer in Asia

T2 - consensus statement from the Asian Oncology Summit 2009

AU - Tangjitgamol, Siriwan

AU - Anderson, Benjamin O.

AU - See, Hui Ti

AU - Lertbutsayanukul, Chawalit

AU - Sirisabya, Nakarin

AU - Manchana, Tarinee

AU - Ilancheran, Arunachalam

AU - Lee, Khai Mun

AU - Lim, Siew Eng

AU - Chia, Yin Nin

AU - Domingo, Efren

AU - Kim, Young Tak

AU - Lai, Chyong Huey

AU - Dali, Ahmad Zailani Hatta Mohd

AU - Supakapongkul, Wisit

AU - Wilailak, Sarikapan

AU - Tay, Eng Hseon

AU - Kavanagh, John

PY - 2009/11

Y1 - 2009/11

N2 - Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.

AB - Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.

KW - ADJUVANT TREATMENT

KW - FOLLOW-UP

KW - INTERMEDIATE-RISK

KW - MRC ASTEC

KW - PELVIC RADIATION-THERAPY

KW - PHASE-III TRIAL

KW - POSTOPERATIVE RADIOTHERAPY

KW - RANDOMIZED-TRIAL

KW - REPLACEMENT THERAPY

KW - STAGE-I

UR - https://www.scopus.com/pages/publications/71249155601

U2 - 10.1016/S1470-2045(09)70290-6

DO - 10.1016/S1470-2045(09)70290-6

M3 - 文献综述

C2 - 19880066

AN - SCOPUS:71249155601

SN - 1470-2045

VL - 10

SP - 1119

EP - 1127

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 11

ER -

Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this